Risk of hyperkalemia associated with selective COX-2 inhibitors.
about
Utilizing an integrated infrastructure for outcomes research: a systematic review.The association between nonsteroidal anti-inflammatory drugs and potassium concentrations: A pharmacoepidemiological study in Saudi ArabiaDrug-induced hyperkalemia.Risk factors for hyperkalaemia in a cohort of patients with newly diagnosed heart failure: a nested case-control study in UK general practice.
P2860
Risk of hyperkalemia associated with selective COX-2 inhibitors.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risk of hyperkalemia associated with selective COX-2 inhibitors.
@ast
Risk of hyperkalemia associated with selective COX-2 inhibitors.
@en
Risk of hyperkalemia associated with selective COX-2 inhibitors.
@nl
type
label
Risk of hyperkalemia associated with selective COX-2 inhibitors.
@ast
Risk of hyperkalemia associated with selective COX-2 inhibitors.
@en
Risk of hyperkalemia associated with selective COX-2 inhibitors.
@nl
prefLabel
Risk of hyperkalemia associated with selective COX-2 inhibitors.
@ast
Risk of hyperkalemia associated with selective COX-2 inhibitors.
@en
Risk of hyperkalemia associated with selective COX-2 inhibitors.
@nl
P2093
P2860
P356
P1476
Risk of hyperkalemia associated with selective COX-2 inhibitors.
@en
P2093
D Craig Brater
Hisham Aljadhey
Michael D Murray
Richard A Hansen
Susan Blalock
P2860
P304
P356
10.1002/PDS.2011
P577
2010-11-01T00:00:00Z